• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的乳腺癌筛查HIP项目分析。

A model-based analysis of the HIP project for breast cancer screening.

作者信息

van Oortmarssen G J, Habbema J D, Lubbe J T, van der Maas P J

机构信息

Department of Public Health and Social Medicine, Medical Faculty, Erasmus University Rotterdam, The Netherlands.

出版信息

Int J Cancer. 1990 Aug 15;46(2):207-13. doi: 10.1002/ijc.2910460211.

DOI:10.1002/ijc.2910460211
PMID:2384271
Abstract

A computer simulation approach is used to test assumptions about sensitivity of mammography and physical examination, and about the duration of preclinical screen-detectable breast cancer. Values between 50% and 80% for the combined sensitivity of the 2 tests give a good explanation of the results of the HIP randomized trial of breast cancer screening. The mean duration of the preclinical stage can vary from 1.6 years for high sensitivity values to 2.7 years for low values. In comparison with previous analyses of the HIP data our estimate for the sensitivity is lower, and the mean duration of the preclinical stage is longer. This is a consequence of the use of a more detailed model in our analysis, allowing for a more complete use of the HIP data in testing model assumptions. Similar analyses of data from recent screening projects in The Netherlands resulted in compatible estimates for the duration of preclinical breast cancer.

摘要

采用计算机模拟方法来检验关于乳房X线摄影和体格检查的敏感性以及临床前可筛查出的乳腺癌持续时间的假设。两种检查联合敏感性在50%至80%之间的值能够很好地解释乳腺癌筛查HIP随机试验的结果。临床前阶段的平均持续时间可能从高敏感性值时的1.6年到低敏感性值时的2.7年不等。与之前对HIP数据的分析相比,我们对敏感性的估计更低,临床前阶段的平均持续时间更长。这是我们在分析中使用了更详细模型的结果,使得在检验模型假设时能够更充分地利用HIP数据。对荷兰近期筛查项目数据的类似分析得出了与临床前乳腺癌持续时间相符的估计。

相似文献

1
A model-based analysis of the HIP project for breast cancer screening.基于模型的乳腺癌筛查HIP项目分析。
Int J Cancer. 1990 Aug 15;46(2):207-13. doi: 10.1002/ijc.2910460211.
2
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?乳腺钼靶摄影的辐射风险与筛查项目中的获益相关:利弊平衡是否有利?
J Med Screen. 1998;5(2):81-7. doi: 10.1136/jms.5.2.81.
3
A model for breast cancer screening.
Cancer. 1990 Oct 1;66(7):1601-12. doi: 10.1002/1097-0142(19901001)66:7<1601::aid-cncr2820660727>3.0.co;2-o.
4
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.瑞典乳腺癌筛查试验中特定年龄死亡率降低的定量解读。
J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23. doi: 10.1093/jnci/87.16.1217.
5
Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.乳腺癌筛查:美国预防服务工作组的证据总结
Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60. doi: 10.7326/0003-4819-137-5_part_1-200209030-00012.
6
Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.加拿大全国乳腺筛查研究:2. 50至59岁女性的乳腺癌检出率和死亡率。
CMAJ. 1992 Nov 15;147(10):1477-88.
7
Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan.乳腺癌定期筛查:健康保险计划(HIP)随机对照试验
J Natl Cancer Inst Monogr. 1997(22):27-30. doi: 10.1093/jncimono/1997.22.27.
8
Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.基于非随机组织筛查数据的乳腺癌自然史参数估计:筛查间隔、敏感性和参检率对降低晚期癌症效果的辅助分析。
Breast Cancer Res Treat. 2010 Jul;122(2):553-66. doi: 10.1007/s10549-009-0701-x. Epub 2010 Jan 7.
9
Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.加拿大全国乳腺筛查研究:1. 40至49岁女性的乳腺癌检出率和死亡率。
CMAJ. 1992 Nov 15;147(10):1459-76.
10
Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.乳腺癌检测示范项目14年随访中40 - 49岁女性获益证据要点。
Cancer. 1994 Jul 1;74(1 Suppl):296-300. doi: 10.1002/cncr.2820741314.

引用本文的文献

1
A Scoping Review on Calibration Methods for Cancer Simulation Models.癌症模拟模型校准方法的范围综述
Med Decis Making. 2025 Aug 11:272989X251353211. doi: 10.1177/0272989X251353211.
2
Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review.定量癌症筛查中临床前可检测阶段的持续时间:系统评价。
Epidemiol Health. 2022;44:e2022008. doi: 10.4178/epih.e2022008. Epub 2022 Jan 3.
3
Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors.
基于基因、肿瘤表型、临床特征和传统危险因素的个体化乳腺癌筛查。
Br J Cancer. 2013 Jun 11;108(11):2241-9. doi: 10.1038/bjc.2013.202. Epub 2013 May 14.
4
An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.基于马尔可夫链模型的家族性鼻咽癌序贯筛查效果分析。
Fam Cancer. 2011 Mar;10(1):133-9. doi: 10.1007/s10689-010-9397-7.
5
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
6
Estimation of progression of multi-state chronic disease using the Markov model and prevalence pool concept.使用马尔可夫模型和患病率池概念估计多状态慢性病的进展情况。
BMC Med Inform Decis Mak. 2007 Nov 9;7:34. doi: 10.1186/1472-6947-7-34.
7
Identifiability of the joint distribution of age and tumor size at detection in the presence of screening.在存在筛查的情况下,检测时年龄与肿瘤大小联合分布的可识别性。
Math Biosci. 2007 Aug;208(2):644-57. doi: 10.1016/j.mbs.2006.12.004. Epub 2007 Jan 12.
8
Age-specific sensitivities of mammographic screening for breast cancer.
Breast Cancer Res Treat. 1996;38(2):153-60. doi: 10.1007/BF01806669.
9
Changes in use of breast-conserving therapy in years 1978-2000.1978年至2000年保乳治疗的使用变化。
Br J Cancer. 1994 Dec;70(6):1165-70. doi: 10.1038/bjc.1994.466.